Suraj Kalia
Stock Analyst at Oppenheimer
(3.49)
# 853
Out of 4,902 analysts
81
Total ratings
46.38%
Success rate
6.63%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Initiates: Perform | n/a | $61.73 | - | 1 | Jul 7, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $15.59 | +41.16% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $111.74 | +34.24% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $29.75 | +51.26% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $7.66 | +200.26% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $136.79 | -12.27% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $30.49 | +4.95% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $81.60 | +13.97% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $125.30 | +3.75% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $4.76 | +110.30% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 | $77.21 | +16.57% | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $8.14 | +59.80% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $113.47 | +18.97% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $256.98 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $9.78 | +206.91% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $3.24 | +6,072.84% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $75.90 | +27.80% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $21.29 | +31.52% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $1.87 | +141.29% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $2.40 | +566.67% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $519.14 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.50 | +26,252.57% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $128.00 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $5.24 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $27.92 | +258.17% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $84.10 | - | 5 | Sep 12, 2018 |
PROCEPT BioRobotics
Jul 7, 2025
Initiates: Perform
Price Target: n/a
Current: $61.73
Upside: -
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $15.59
Upside: +41.16%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $111.74
Upside: +34.24%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $29.75
Upside: +51.26%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $7.66
Upside: +200.26%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $136.79
Upside: -12.27%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $30.49
Upside: +4.95%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $81.60
Upside: +13.97%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $125.30
Upside: +3.75%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $4.76
Upside: +110.30%
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $77.21
Upside: +16.57%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $8.14
Upside: +59.80%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $113.47
Upside: +18.97%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $256.98
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $9.78
Upside: +206.91%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $3.24
Upside: +6,072.84%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $75.90
Upside: +27.80%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $21.29
Upside: +31.52%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $1.87
Upside: +141.29%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $2.40
Upside: +566.67%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $519.14
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.50
Upside: +26,252.57%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $128.00
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $5.24
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $27.92
Upside: +258.17%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $84.10
Upside: -